Clinical trialNCT01450709CompletedObservational

Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis

SponsorKibow PharmaEnrollment30Chronic Kidney Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A specifically formulated probiotic product comprised of defined and tested microbial strains may afford renoprotection in what has been generally called "Enteric DialysisTM". However, it is also referred to as enteric toxin reduction technology. Our hypothesis is to assess the potential benefits in devising a bowel-based probiotic formulation (Kibow® Biotics/RenadylTM) as a dietary supplement product for patients undergoing dialysis along with standardized care of treatment.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Eli Friedman, M.D., MACP, FRCP
Downstate Medical Center
Principal Investigator
clinicaltrials.gov ↗
Gary Briefel, M.D.
Kings County Medical Center
Principal Investigator
clinicaltrials.gov ↗
Mary Mallapallil, M.D.
Kings County Medical Center
Principal Investigator
clinicaltrials.gov ↗
Subodh J Saggi, M.D., MPH
Downstate Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Parkside Dialysis Clinic at Downstate Medical Center
Brooklyn, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2011
Primary completion: 30 Sept 2012
Completion: 31 Oct 2012
Last update posted: 20 Aug 2019
Registered enrollment: 30
Registry id: NCT01450709

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.